Literature DB >> 9395524

Platelet factor 4 binds to glycanated forms of thrombomodulin and to protein C. A potential mechanism for enhancing generation of activated protein C.

A Z Dudek1, C A Pennell, T D Decker, T A Young, N S Key, A Slungaard.   

Abstract

Platelet factor 4 (PF4) is an abundant platelet alpha-granule heparin-binding protein. We have previously shown that PF4 accelerates up to 25-fold the proteolytic conversion of protein C to activated protein C by the thrombin.thrombomodulin complex by increasing its affinity for protein C 30-fold. This stimulatory effect requires presence of the gamma-carboxyglutamic acid (Gla) domain in protein C and is enhanced by the presence of a chondroitin sulfate glycosaminoglycan (GAG) domain on thrombomodulin. We hypothesized that cationic PF4 binds to both protein C and thrombomodulin through these anionic domains. Qualitative SDS-polyacrylamide gel electrophoresis analysis of avidin extracts of solutions containing biotinylated PF4 and candidate ligands shows that PF4 binds to GAG+ but not GAG- forms of thrombomodulin and native but not Gla-domainless protein C. Quantitative analysis using the surface plasmon resonance-based BIAcoreTM biosensor system confirms the extremely high affinity of PF4 for heparin (KD = 4 nM) and shows that PF4 binds to GAG+ thrombomodulin with a KD of 31 nM and to protein C with a KD of 0.37 microM. In contrast, PF4 had no measurable interaction with GAG- thrombomodulin or Gla-domainless protein C. Western blot analysis of normal human plasma extracted with biotinylated PF4 demonstrates PF4 binding to protein C in a physiologic context. Thus, PF4 binds with relative specificity and high affinity to the GAG- domain of thrombomodulin and the Gla domain of protein C. These interactions may enhance the affinity of the thrombin.thrombomodulin complex for protein C and thereby promote the generation of activated protein C.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9395524     DOI: 10.1074/jbc.272.50.31785

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.

Authors:  Laurent O Mosnier
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

2.  Involvement of human natural killer-1 (HNK-1) sulfotransferase in the biosynthesis of the GlcUA(3-O-sulfate)-Gal-Gal-Xyl tetrasaccharide found in α-thrombomodulin from human urine.

Authors:  Taishi Hashiguchi; Shuji Mizumoto; Yuko Nishimura; Jun-ichi Tamura; Shuhei Yamada; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2011-08-02       Impact factor: 5.157

3.  Platelet Factor 4 Binds to Vascular Proteoglycans and Controls Both Growth Factor Activities and Platelet Activation.

Authors:  Megan S Lord; Bill Cheng; Brooke L Farrugia; Simon McCarthy; John M Whitelock
Journal:  J Biol Chem       Date:  2017-01-23       Impact factor: 5.157

4.  Antibodies associated with heparin-induced thrombocytopenia (HIT) inhibit activated protein C generation: new insights into the prothrombotic nature of HIT.

Authors:  M Anna Kowalska; Sriram Krishnaswamy; Lubica Rauova; Li Zhai; Vincent Hayes; Karine Amirikian; Jeffrey D Esko; Daniel W Bougie; Richard H Aster; Douglas B Cines; Mortimer Poncz
Journal:  Blood       Date:  2011-07-19       Impact factor: 22.113

5.  Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: clinical and therapeutic implications.

Authors:  Michele P Lambert; Lubica Rauova; Matthew Bailey; Martha C Sola-Visner; M Anna Kowalska; Mortimer Poncz
Journal:  Blood       Date:  2007-05-10       Impact factor: 22.113

6.  A surface plasmon resonance-based solution affinity assay for heparan sulfate-binding proteins.

Authors:  Siska Cochran; Cai Ping Li; Vito Ferro
Journal:  Glycoconj J       Date:  2008-11-26       Impact factor: 2.916

Review 7.  The marriage of chemokines and galectins as functional heterodimers.

Authors:  Philipp von Hundelshausen; Hans-Joachim Gabius; Kevin H Mayo; Kanin Wichapong
Journal:  Cell Mol Life Sci       Date:  2021-11-12       Impact factor: 9.261

Review 8.  Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.

Authors:  Helena Crijns; Vincent Vanheule; Paul Proost
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

9.  The C5a/C5a receptor 1 axis controls tissue neovascularization through CXCL4 release from platelets.

Authors:  Henry Nording; Lasse Baron; David Haberthür; Frederic Emschermann; Matthias Mezger; Manuela Sauter; Reinhard Sauter; Johannes Patzelt; Kai Knoepp; Anne Nording; Moritz Meusel; Roza Meyer-Saraei; Ruslan Hlushchuk; Daniel Sedding; Oliver Borst; Ingo Eitel; Christian M Karsten; Robert Feil; Bernd Pichler; Jeanette Erdmann; Admar Verschoor; Emmanouil Chavakis; Triantafyllos Chavakis; Philipp von Hundelshausen; Jörg Köhl; Meinrad Gawaz; Harald F Langer
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.